| R2033134 |
KHS101 |
KHS101 could selectively induce a neuronal differentiation phenotype and interac
|
| R2033135 |
KHS101 hydrochloride |
KHS101 hydrochloride could selectively induce a neuronal differentiation phenoty
|
| R2033136 |
LJ570 |
LJ570 is a PPARα/PPARγ dual agonist with EC50s of 1.05 and 0.12 μM, respectively
|
| R2033137 |
LX-2343 |
LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM.LX2343 ac
|
| R2033138 |
MHP |
MHP (Methyl caprooyl tyrosinate) is an activator of sphingosine kinase (SPHK1),
|
| R2033139 |
MK-3903 |
MK-3903 is a potent and selective AMP-activated protein kinase (AMPK) activator
|
| R2033140 |
NMS-1286937 |
NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an
|
| R2033141 |
Risdiplam |
Risdiplam (RG7916; RO7034067) is an orally administered, centrally and periphera
|
| R2033142 |
TAK931 |
Simurosertib (TAK-931) is a selective cycle 7 (CDC7) kinase inhibitor, with an I
|
| R2033143 |
VL285 |
VL285 is a potent VHL ligand with an IC50 of 0.34 μM.
|
| R2033144 |
WHI-P97 |
WHI-P97 is a rationally designed potent inhibitor of JAK-3.IC50 value: Target: J
|
| R2033145 |
RN1747 |
RN-1747 is a selective transient receptor potential cation channel subfamily V m
|
| R2033146 |
D-Lin-MC3-DMA |
D-Lin-MC3-DMA, an ionizable cationic lipid, is a potent siRNA delivery vehicle.
|
| R2033147 |
ERK5-IN-1 |
ERK5-IN-1 is a potent ERK5 inhibitor with an IC50 of 87±7 nM.ERK5-IN-1 also inhi
|
| R2033148 |
Cl-amidine trifluoroacetate salt |
Cl-amidine is a peptidylarginine deminase (PAD) inhibitor, with an IC50 5.9 μM f
|
| R2033149 |
Cl-amidine |
Cl-amidine is a peptidylarginine deminase (PAD) inhibitor, with an IC50 5.9 μM f
|
| R2033150 |
Cl-amidine hydrochloride |
Cl-amidine (hydrochloride) is a peptidylarginine deminase (PAD) inhibitor, with
|
| R2033151 |
GW788388 |
GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, and als
|
| R2033152 |
MDK7526 |
(S,R,S)-AHPC (MDK7526) is the VH032-based VHL ligand used in the recruitment of
|
| R2033153 |
Acrizanib |
Acrizanib is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-KDR.
|
| R2033154 |
TC13172 |
TC13172 is a mixed lineage kinase domain-like protein (MLKL) inhibitor with an E
|
| R2033155 |
RMC-4550 |
RMC-4550 is a potent, selective and allosteric inhibitor of SHP2, with an IC50 o
|
| R2033156 |
G1T38;Lerociclib |
Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of
|
| R2033157 |
cFMS Receptor Inhibitor II |
cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor.CSF-1 is a cytokine.
|
| R2033158 |
MM102 |
MM-102 (HMTase Inhibitor IX) is a potent WDR5/MLL interaction inhibitor, achieve
|